National Health Investors (NHI) Financials
Key financial figures for National Health Investors (Q2 2026).
National Health Investors posted Q2 2026 diluted EPS of $1.15 (up 45.6% YoY) as SHOP segment NOI grew 188% and the NHC portfolio sale closed, while Normalized FFO per diluted share held at $1.19 versus $1.22 a year ago. Net income attributable to common stockholders was $1.15 per diluted share, up 45.6% from $0.79 in Q2 2025, boosted by $22.0 million of gains on real estate dispositions. Normalized FFO per diluted share was $1.19, down 2.5% from $1.22 in Q2 2025; NAREIT FFO per diluted share was flat at $1.19 in both periods. Normalized FAD was $61.6 million, up from $56.0 million a year ago. On the outlook: NHI maintained its 2026 full-year guidance of $4.74-$4.79 Normalized FFO per diluted share and $240.6M-$243.7M Normalized FAD (both unchanged from the reduced range first issued with Q1 2026 results, down from the original $4.94-$4.99 range issued with FY2025 results, reflecting the NHC portfolio sale). Figures are for Q2 2026, as National Health Investors reported them.
- Revenue
- $121M
- Net Income
- $56M
- EPS
- $1.15
- Total Assets
- $3.0B
- Operating Cash Flow
- $65M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q2 FY2026 | $121M | $56M | $1.15 | ||
| Q1 FY2026 | $116M | $40M | $0.82 | $51M | |
| Q4 FY2025 | $107M | $38M | $0.80 | $59M | |
| Q3 FY2025 | $90M | $33M | $0.69 | $58M | |
| Q2 FY2025 | $91M | $37M | $0.79 | $59M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $379M | $142M | $3.02 | $220M | |
| FY2024 | $335M | $138M | $3.13 | $192M | |
| FY2023 | $320M | $136M | $3.13 | $181M |
Frequently asked questions
What was National Health Investors's revenue last quarter?
National Health Investors reported revenue of $121.3 million for Q2 FY2026, up 33.8% from the same period a year earlier.
Is National Health Investors profitable?
Yes. National Health Investors reported net income of $55.7 million for Q2 FY2026, a net margin of 45.89% on revenue.
When does National Health Investors report next?
National Health Investors is scheduled to report Q3 2026 results on 2026-11-09. That date is an estimate and has not been confirmed by the company.
Full income statement, balance sheet and cash flow for National Health Investors on SentiSense, with up to forty quarters and twenty fiscal years of history.